Alpha Dna Investment Management LLC Immuno Gen, Inc. Transaction History

Alpha Dna Investment Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$14.09 - $19.87 $505,774 - $713,253	35,896 New	35,896 $569,000
Q1 2022 May 13, 2022	SELL	$4.26 - $7.48 $924,620 - $1.62 Million	-217,047 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$4.75 - $7.5 $1.03 Million - $1.63 Million	217,047 New	217,047 $1.61 Million

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Alpha Dna Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Dna Investment Management LLC with notifications on news.